SGRY SURGERY PARTNERS
Health Care · Russell 2000
Next earnings: Mon 9 Nov 2026 · estimated
What 15 analyst firms say about SURGERY PARTNERS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
13 rated views · 15 analyst/firm records · 15 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Average target is not above the current price
- Russell 2000 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 18 reports on SGRY from 12 analyst firms in the last 90 days (16 firms in the past year).
Comparing each firm's latest target with its previous one: 4 raised their price target, 1 lowered it, 2 left it unchanged and 1 has its first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 5 downgrades.
Latest observed target change: Cowen raised its target from $19.00 (set 18 Sep 2026) to $23.50 on 31 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Andrew Mok | Hold | 28 Aug 2026 | 14.00 USD |
| Benchmark | William Sutherland | Hold | 27 Oct 2026 | 24.00 USD |
| Cantor Fitzgerald | Sarah James | Hold | 26 Oct 2026 | 23.50 USD |
| Jefferies | Brian G Tanquilut | Buy | 10 Jul 2026 | 20.00 USD |
| JPMorgan | Benjamin Rossi | Hold | 14 Sep 2026 | 15.00 USD |
| KeyBanc Capital Markets | Matthew Gillmor | Hold | 10 Aug 2026 | — |
| Leerink Partners | Whit Mayo | Buy | 3 Mar 2026 | 18.00 USD |
| Mizuho | Ann K Hynes | Buy | 13 Jul 2026 | 19.00 USD |
| RBC Capital Markets | Ben Hendrix | Hold | 26 Oct 2026 | 23.50 USD |
| Stonex Financia | Unnamed analyst | Hold | 27 Oct 2026 | — |
| TD Cowen | Ryan Langston | Hold | 31 Oct 2026 | 23.50 USD |
| UBS | A.J. Rice | Hold | 28 Oct 2026 | 23.50 USD |
| US Capital Advisors | Unnamed analyst | — | 11 Mar 2026 | 21.00 USD |
| Weiss Ratings | Unnamed analyst | — | 16 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 10 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:03 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.